For the PP sample, there was a clinically meaningful reduction in anxiety symptoms from baseline to final score in the digital program group (mean GAD-7 change –7.4, 95% CI –8.1 to –6.7, d=1.6; Figure 5 and Table 4). This evidence concerns the gene GAD1 and Anxiety.